IP Library Granted Patent US 8,461,088
Granted Patent B2
US 8,461,088 · App. 12/376,896 · Granted Jun 11, 2013

Method of scale inhibition

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,461,088
App. No.
12/376,896
Granted
Jun 11, 2013
Kind
B2
Abstract

A method is disclosed to inhibit scale formation in aqueous systems whereby a threshold amount of a scale inhibiting agent, represented by an aminoacid alkylphosphonic acid, is added to the aqueous system. The aminoacid moiety can be represented by α-species or by species having, at least, two or more carbon atoms between the carboxylic moiety and the amine group. These aminoacid based inhibitors exhibit unusually superior performance and system acceptability compared to leading state-of-the-art inhibitors.

Claims (50)

1. A method for oil recovery comprising the step of injecting into marine oil wells an aqueous solution of an aminoacid phosphonic acid scale inhibitor in a level of from 0.1 to 100000 ppm, where the scale inhibitor is selected from the group consisting of:

i. aminoacid alkylphosphonic acids having the formula

A 1 -(B) x

wherein A 1 has the formula

HOOC-A-NH 2

wherein A is independently selected from C 2 -C 20 linear, branched, cyclic or aromatic hydrocarbon chains, optionally substituted by C 1 -C 12 linear, branched, cyclic or aromatic hydrocarbon groups, optionally substituted by OH, COOH and/or NH 2 moieties, and

B is an alkylphosphonic acid moiety having from 1 to 6 carbon atoms in the alkyl group and x is an integer of from 1 to 10, and

ii. aminoacid alkylphosphonic acids having the formula

A 2 -B y

wherein A 2 has the formula

HOOC—C(NH 2 )(R)(R′)

wherein R and R′ are independently selected from C 1 -C 20 linear, branched, cyclic or aromatic hydrocarbon chains, optionally substituted by C 1 -C 12 linear, branched, cyclic or aromatic NH 2 and/or COOH, and one of R or R′ can be hydrogen with the proviso of excluding:

compounds wherein R and/or R′ are electron rich moieties containing, at least, one lone pair of electrons, which moiety is directly attached to an aromatic moiety by a covalent bond; or aromatics wherein at least one of the carbon atoms has been substituted by a heteroatom; and

compounds, in the event R is —C(X)(R″)(R′″) and R′, R″ and R′″ are hydrogen wherein X is an electron withdrawing group selected from NO 2 , CN, COOH, SO 3 H, OH and halogen, and with the further proviso that when:

A 2 is L-lysine, at least one L-lysine amino radical carries 2 (two) alkyl phosphonic acid moieties; and when

A 2 is L-glutamic acid, the term glutamic acid phosphonate represents a combination of from 50-90% by weight pyrrolidone carboxylic acid N-methylene phosphonic acid and from 10-50% by weight of L-glutamic acid diphosphonic acid, expressed on the basis of the reaction products; and

B is an alkylphosphonic acid moiety having from 1 to 6 carbon atoms in the alkyl group and y is an integer in the range of from 1 to 10.

2. The method for oil recovery in accordance with claim 1 wherein an aqueous solution containing of from 0.1 to 800 ppm of the aminoacid phosphonic acid compound is continuously injected into the well.

3. The method for oil recovery in accordance with claim 1 comprising, in sequence: stopping the production wellbore activity; introducing through the production wellbore the aqueous treatment solution comprising the aminoacid phosphonic acid scale inhibitor in a level of from 100 to 100000 ppm; injecting sea water through the production wellbore to place the scale inhibitor within the targeted area of the formation; restarting the oil extraction activity; and producing return fluids, containing oil and return water, through the production wellbore.

4. The method in accordance with claim 1 wherein the scale inhibitor is selected from the group of:

i. aminoacid alkylphosphonic acids having the formula

A 1 -(B) x

wherein A 1 is

7-aminoheptanoic acid;

6-aminohexanoic acid;

5-aminopentanoic acid;

4-aminobutyric acid; and

β-alanine;

B is an alkylphosphonic acid moiety having from 1 to 6 carbon atoms in the alkyl group and x is 2 in each of such species;

and from the group of:

ii. aminoacid alkylphosphonic acids having the formula

A 2 -B y

wherein A 2 is

α-alanine;

L-lysine;

L-glutamic acid;

L-phenylalanine;

L-methionine; and

L-cysteine;

with the proviso that when:

A 2 is L-lysine, at least one L-lysine amino radical carries 2 (two) alkyl phosphonic acid moieties; and when

A 2 is L-glutamic acid, the term glutamic acid phosphonate represents a combination of from 50-90% by weight pyrrolidone carboxylic acid N-methylene phosphonic acid and from 10-50% by weight of L-glutamic acid diphosphonic acid, expressed on the basis of the reaction products; and

B is an alkylphosphonic acid moiety having from 1 to 6 carbon atoms in the alkyl group and y is from 2 to 4 for L-lysine,

y is from 1 to 2 for L-glutamic acid and y is 2 in each of the other species;

said inhibitor being present, in the return water, in a level of from 0.1 to 20 ppm.

5. The method in accordance with claim 1 whereby in the event a mixture of the scale inhibitors is used one of the individual scale inhibitors shall constitute, on a ponderal basis, 60% by weight or more of the ponderal sum of the total scale inhibitors.

6. The method in accordance with claim 1 wherein the scale inhibitor has a thermal stability, measured at 140° C., of at least about 90% by weight, whereby the aminoacid moiety in said scale inhibitor is selected from the group of α-alanine, L-glutamic acid, L-lysine, L-phenylalanine, D,L-leucine, L-methionine, 5-aminopentanoic acid, 6-aminohexanoic acid and 7-aminoheptanoic acid, said aminoacid moieties being attached to two alkylphosphonic acid moieties, except L-lysine containing from 2 to 4 alkylphosphonic acid moieties and L-glutamic acid containing 1 to 2 alkylphosphonic acid moieties.

7. The method in accordance with claim 1 wherein the L-lysine alkylene phosphonate is represented by a mixture of L-lysine di(alkylene phosphonic acid) and L-lysine tetra(alkylene phosphonic acid) whereby the weight ratio of L-lysine tetra(alkylene phosphonic acid) to L-lysine di(alkylene phosphonic acid) is in the range of from 9:1 to 1:1.

8. The method in accordance with claim 7 wherein the weight ratio of lysine tetra(alkylene phosphonic acid) to L-lysine di(alkylene phosphonic acid) is in the range of from 7:2 to 4:2.

9. The method in accordance with claim 1 wherein L-lysine carrying one alkylene phosphonic acid group attached to amino radical(s) represents not more than 20 molar % of the sum of L-lysine carrying one and two alkylene phosphonic acid groups attached to amine radicals.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2014
From: DEQUEST AG
To: ITALMATCH CHEMICALS SPA
Reel/Frame 032342/0281 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2010
From: THERMPHOS TRADING GMBH
To: DEQUEST AG
Reel/Frame 024430/0175 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2009
From: NOTTE, PATRICK P.B.; DEVAUX, ALBERT; VAN BREE, JAN H.J.; JOHNSON, TESSA
To: THERMPHOS TRADING GMBH
Reel/Frame 022686/0131 →